Trial
NCT04870125
Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
Weill Medical College of Cornell University; Massachusetts General Hospital; Duke University; National Heart, Lung, and Blood Institute (NHLBI); Washington University School of Medicine
Condition
Acute Respiratory Distress Syndrome
Intervention
Inhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%)
Why stopped
Due to low enrollment, the study was halted early.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-26